EMVision secures USD 10Mln investment from Keysight technologies
EMVision, an Australian medical device company focused on developing innovative portable brain imaging technology, has announced a US$10 million (~A$15.28m) strategic investment from Keysight Technologies, a global leader in test and measurement technology. The investment provides EMVision with a fully funded commercial runway for its emu™ device. It accelerates clinical trials, generating essential data supporting […]
